T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report) was the recipient of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 18,700 shares, anincreaseof1,146.7% from the June 30th total of 1,500 shares. Based on an average trading volume of 275,800 shares, the days-to-cover ratio is currently 0.1 days. Based on an average trading volume of 275,800 shares, the days-to-cover ratio is currently 0.1 days.
Analyst Ratings Changes
Separately, Wall Street Zen started coverage on shares of T2 Biosystems in a research note on Wednesday, May 21st. They set a “sell” rating on the stock.
View Our Latest Report on T2 Biosystems
T2 Biosystems Trading Up 344.4%
About T2 Biosystems
T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
Recommended Stories
- Five stocks we like better than T2 Biosystems
- Short Selling – The Pros and Cons
- Why Teradyne’s 19% Rally Is Just Getting Started
- Why Are Stock Sectors Important to Successful Investing?
- Buy the Dip on 3 Overlooked Names With Major Potential
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Bitcoin and Dividends: A Winning Combo in These 3 ETFs
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.